Decreased antibody response after SARS-CoV-2 vaccination in patients with Down Syndrome.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Streng, Bianca M MBont, Marin
Delemarre, Eveline M
Binnendijk, Rob S
Smit, Gaby
den Hartog, Gerco
Coppus, Antonia M W
de Vries, Esther
Weijerman, Michel E
Lamberts, Regina
de Graaf, Gert
van der Klis, Fiona R
Vidarsson, Gestur
Rave, Neele
Bont, Louis J
Wildenbeest, Joanne G
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Decreased antibody response after SARS-CoV-2 vaccination in patients with Down Syndrome.Published in
The Journal of infectious diseases 2022 Jun 24;jiac235PMID
35748853ae974a485f413a2113503eed53cd6c53
10.1093/infdis/jiac235
Scopus Count
Collections
Related articles
- Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.
- Authors: Jalkanen P, Kolehmainen P, Haveri A, Huttunen M, Laine L, Österlund P, Tähtinen PA, Ivaska L, Maljanen S, Reinholm A, Belik M, Smura T, Häkkinen HK, Ortamo E, Kantele A, Julkunen I, Lempainen J, Kakkola L
- Issue date: 2022 Apr 27
- Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study.
- Authors: Barin B, Kasap U, Selçuk F, Volkan E, Uluçkan Ö
- Issue date: 2022 Apr
- Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?
- Authors: Ogura W, Ohtsuka K, Matsuura S, Okuyama T, Matsushima S, Yamasaki S, Miyagi H, Sekiguchi K, Ohnishi H, Watanabe T
- Issue date: 2022 May 3
- Factors associated with anti-SARS-CoV-2 spike antibody titers after a second BNT162b2 mRNA COVID-19 vaccination in Japanese hemodialysis patients.
- Authors: Hirai K, Shimotashiro M, Sonoda T, Okumura T, Ookawara S, Morishita Y
- Issue date: 2022 Sep
- Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
- Authors: Choi JH, Kim YR, Heo ST, Oh H, Kim M, Lee HR, Yoo JR
- Issue date: 2022